FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ATACAND (candesartan cilexetil) submitted by ANI Pharmaceuticals, Inc., to modify or expand the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Atacand (candesartan)

Snippet

SUPPL AP for ATACAND (CANDESARTAN CILEXETIL)